Fig. 3From: Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trialPharmacokinetics of levosimendan and its metabolites during and after infusion (statistics all patients including infusion duration < 24 h, 24–48 h, and 48 h). a Pharmacokinetics of levosimendan. b Pharmacokinetics of levosimendan metabolitesBack to article page